Chemotherapy News and Research

Latest Chemotherapy News and Research

Membrane lipid stops stress reactions and inhibits cell death

Programmed cell death is an important tool that an organism uses to keep itself healthy. When a cell does not function as it should, various stress reactions are activated. The goal of these reactions is to restore the original cell function.

1 Jun 2022

Black patients with early-onset colorectal cancer receive worse, less timely care than white counterparts

In a new large national study led by researchers at the American Cancer Society, Black patients diagnosed with early-onset colorectal cancer received worse and less timely care than their white counterparts.

31 May 2022

Scientists develop new way to attack synovial sarcoma using an investigational drug

Researchers at Washington University School of Medicine in St. Louis have developed a way to attack synovial sarcoma - a rare tumor of soft tissues, such as ligaments and muscles - using an investigational drug that triggers cell death.

31 May 2022

Study: Cardiovascular mortality risk differs among cancer survivors by race/ethnicity and cancer types

A new large national study led by researchers at the American Cancer Society shows the mortality risk from cardiovascular disease (CVD) differs considerably among cancer survivors by race/ethnicity and cancer types.

31 May 2022

New discovery could pave the way for more effective cancer immunotherapy

A type of white blood cell previously known only as a helper in the immune system appears also to be the instigator of the body's defenses against cancerous tumors.

31 May 2022

New compounds for cancer immunotherapy via STING-mediated immune activation

Innovations in cancer immunotherapy have achieved clinical success by considerably increasing the survival rate of patients undergoing cancer treatment.

31 May 2022

Renowned pharmaceutical scientist will collaborate with JGU professor to reduce side effects of chemotherapy

The internationally renowned pharmaceutical scientist Professor Hans Lennernäs of Uppsala University has been given a Humboldt Research Award worth EUR 60,000 by the Alexander von Humboldt Foundation.

30 May 2022

Novel photonic technology could enable fluorescent sensors to track molecules deep inside the body

Fluorescent sensors, which can be used to label and image a wide variety of molecules, offer a unique glimpse inside living cells.

30 May 2022

Medical cannabis use shown to improve cancer-related symptoms in new study

Researchers describe the effectiveness and safety of medical cannabis use for treating cancer-related symptoms.

30 May 2022

Risk factors for COVID-19 in patients with hematological malignancies

Researchers investigate the risk factors present in individuals suffering from hematological malignancies and COVID-19.

26 May 2022

Children from historically marginalized groups or poor backgrounds less likely to survive neuroblastoma

Children with high-risk neuroblastoma had worse outcomes if they were from certain racial/ethnic groups or were on public rather than private insurance, despite being treated in clinical trials with standardized protocols, according to a study led by investigators from Dana-Farber/Boston Children's Cancer and Blood Disorders Center.

26 May 2022

New initiative aims to increase collaboration and accelerate high-impact cancer immunotherapy

The accelerated advancement of cancer immunology and immunotherapy, a type of biological therapy that boosts the immune system's ability to recognize and kill cancer cells, has significantly improved the effectiveness of cancer treatment and patient outcomes.

25 May 2022

NYU Abu Dhabi research could pave the way for more effective cancer treatments

A team led by Professor of Biology, Senior Vice Provost of Research at NYU Abu Dhabi, and UAE national Sehamuddin Galadari, has discovered a novel structural modification in AMP-activated protein kinase (AMPK) during anticancer therapy that could pave the way for the development of more effective cancer treatments.

25 May 2022

Case Western Reserve signs license agreement to bring groundbreaking AI for helping cancer patients

When Case Western Reserve University research showed that artificial intelligence (AI) could identify which lung cancer patients would benefit from chemotherapy, a national magazine called the finding one of the "10 Most Incredible Medical Breakthroughs of 2018."

25 May 2022

Biodegradable, non-ionic polymeric nanovesicles efficiently encapsulate and deliver siRNA

Small interfering RNAs, or siRNAs, hold promise to treat tumors, through their ability to specifically knock down oncogenes that promote tumor growth, without the toxicity that accompanies chemotherapy. However, the siRNAs need a delivery vehicle to protect them from degradation and clearance on their journey through the bloodstream to the cancer tumor.

25 May 2022

COVID-19 vaccine effectiveness wanes more quickly in cancer patients, study finds

A study co-led by the Universities of Oxford, Birmingham and Southampton and the UK Health Security Agency (UKHSA), published in Lancet Oncology today by the UK Coronavirus Cancer Evaluation Project, has found that while COVID-19 vaccination is effective in most cancer patients, the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

24 May 2022

Research provides insight into genetic mechanisms of Wilms tumor

New research from Ann & Robert H. Lurie Children's Hospital of Chicago and collaborators from other institutions provides insights into some of the genetic characteristics resulting in the development of relapse in patients with Wilms tumor (nephroblastoma), the most common type of pediatric cancer of the kidney.

24 May 2022

To shed bias, doctors get schooled to look beyond obesity

When Melissa Boughton complained to her OB-GYN about dull pelvic pain, the doctor responded by asking about her diet and exercise habits.

24 May 2022

Improving Patient Recruitment for Clinical Trial Research

In this interview, we speak to Matt Walz, CEO of Trialbee, about the importance of improving patient recruitment and retention within clinical trials.

From Trialbee 23 May 2022

Hyperinsulinemic patients with breast cancer may be responsive to metabolism-targeting treatments

Scientists at Yale Cancer Center have found that patients with breast cancer and high levels of insulin in the blood may be responsive to metabolism-targeting treatments, which in turn may improve the effectiveness of subsequent chemotherapy treatments.

20 May 2022

Chemotherapy News and Research

Latest Chemotherapy News and Research

Membrane lipid stops stress reactions and inhibits cell death

Black patients with early-onset colorectal cancer receive worse, less timely care than white counterparts

Scientists develop new way to attack synovial sarcoma using an investigational drug

Study: Cardiovascular mortality risk differs among cancer survivors by race/ethnicity and cancer types

New discovery could pave the way for more effective cancer immunotherapy

New compounds for cancer immunotherapy via STING-mediated immune activation

Renowned pharmaceutical scientist will collaborate with JGU professor to reduce side effects of chemotherapy

Novel photonic technology could enable fluorescent sensors to track molecules deep inside the body

Medical cannabis use shown to improve cancer-related symptoms in new study

Risk factors for COVID-19 in patients with hematological malignancies

Children from historically marginalized groups or poor backgrounds less likely to survive neuroblastoma

New initiative aims to increase collaboration and accelerate high-impact cancer immunotherapy

NYU Abu Dhabi research could pave the way for more effective cancer treatments

Case Western Reserve signs license agreement to bring groundbreaking AI for helping cancer patients

Biodegradable, non-ionic polymeric nanovesicles efficiently encapsulate and deliver siRNA

COVID-19 vaccine effectiveness wanes more quickly in cancer patients, study finds

Research provides insight into genetic mechanisms of Wilms tumor

To shed bias, doctors get schooled to look beyond obesity

Improving Patient Recruitment for Clinical Trial Research

Hyperinsulinemic patients with breast cancer may be responsive to metabolism-targeting treatments

Cancer Research - Second Edition eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in